Patricia Kovacevic

An experienced global legal, regulatory and compliance department leader, Patricia Kovacevic’s career comprises leading senior legal and regulatory positions with FDA-regulated multinationals, including Philip Morris International and Lorillard (now BAT), as well as partner roles with premier global law firms.

At present she provides consulting services to the FDA regulated industries and AI industry through her consulting firm, RegulationStrategy and also serves as Cgief Legal Officer and Head of External Affairs for Cryomass Technologies Inc, a publicly traded U.S. technology and manufacturing company with patented technology in biomass/trichomes separation. Her expertise includes senior management roles and leading multinational, cross-disciplinary teams, with focus on corporate law, FDA and EU regulatory, compliance, M&A, US and global food, drug, nicotine and consumer goods regulation, medicinals regulation, external affairs and the legal framework applicable to marketing, media communications, investigations, FCPA, trade sanctions, privacy, intellectual property, product development and launch.

She also led cross-disciplinary teams engaged in scientific research efforts. Kovacevic served on various trade association bodies and  boards. She authored several articles on nicotine regulation, co-authored an academic treatise, and is often invited as a keynote speaker or panelist before global conferences and government agencies public hearings. Kovacevic holds a Juris Doctor (Doctor of Law) degree from Columbia School and completed the Harvard Business School “Corporate Leader” executive education program. She is an attorney admitted to practice in New York, before the U.S. Tax Court, before the U.S. Court of International Trade and before the Supreme Court of the United States. Kovacevic speaks several languages fluently, including French, Italian, Spanish, Romanian and Croatian. Patricia is open to serving on company boards.